Radical Surgery for Metastatic Prostate Cancer Results in Greater Morbidity
Radical prostatectomy for metastatic vs nonmetastatic prostate cancer is associated with a higher risk of complications and longer hospital length of stay.
EAU Congress
Prostate Cancer Death Risk Lower With Statin Use After ADT Start
In adjusted analyses, statin use after initiation of androgen deprivation therapy for prostate cancer was associated with a significant 26% decreased risk of dying from the disease.
Active Surveillance for Low-Risk Prostate Cancer Safe for Younger Men
Men aged 60 years or younger with low-risk prostate cancer are at no higher risk of disease progression while on active surveillance than older men, study finds.
High Gleason Pattern at PSM Ups Prostate Cancer Relapse Risk
Gleason pattern 4 or 5 found at a positive surgical margin following robot-assisted radical prostatectomy predicts early biochemical recurrence.
Prostate Cancer Mortality Lowest With Radical Prostatectomy
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
Robotic Partial Nephrectomy May Be a Viable Option for Large Renal Tumors
Robotic partial nephrectomy offers similar oncologic outcomes to robotic radical nephrectomy, but is associated with better preservation of renal function.
TRT Speeds Potency Recovery After Prostate Surgery
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
TRT Reduces Post-RARP Recurrence Risk in Low-Risk Prostate Cancer
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Metabolic Syndrome Increases Risk of Kidney Stone Recurrence
Kidney stone recurrence risk increases along with the number of metabolic syndrome components, which include abdominal obesity, hypertension, elevated fasting glucose, low high-density lipoprotein, and elevated triglycerides.
Bladder Cancer Linked to Early Menopause in Smokers
Among women with a history of smoking, menopause onset at age 45 or younger is associated with a 66% higher risk of bladder cancer compared with onset at age 50 or older.
Want to read more?
Please login or register first to view this content.
Next post in Bladder Cancer
